Compare NGS & MOBI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
| Metric | NGS | MOBI |
|---|---|---|
| Founded | 1998 | 2007 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Oilfield Services/Equipment | Medical/Dental Instruments |
| Sector | Energy | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 473.6M | 383.0M |
| IPO Year | 2006 | 2026 |
| Metric | NGS | MOBI |
|---|---|---|
| Price | $31.38 | $10.24 |
| Analyst Decision | Buy | Strong Buy |
| Analyst Count | 3 | 4 |
| Target Price | ★ $56.00 | $17.75 |
| AVG Volume (30 Days) | 69.1K | ★ 134.0K |
| Earning Date | 11-09-2026 | 11-05-2026 |
| Dividend Yield | ★ 1.85% | N/A |
| EPS Growth | ★ 14.60 | N/A |
| EPS | ★ 0.83 | N/A |
| Revenue | ★ $172,315,000.00 | N/A |
| Revenue This Year | $22.97 | $71.88 |
| Revenue Next Year | $19.05 | $43.02 |
| P/E Ratio | $39.00 | ★ N/A |
| Revenue Growth | ★ 9.94 | N/A |
| 52 Week Low | $27.22 | $8.03 |
| 52 Week High | $44.61 | $15.19 |
| Indicator | NGS | MOBI |
|---|---|---|
| Relative Strength Index (RSI) | 42.95 | 53.51 |
| Support Level | $29.91 | $8.24 |
| Resistance Level | $39.23 | $11.55 |
| Average True Range (ATR) | 1.17 | 0.71 |
| MACD | 0.21 | 0.22 |
| Stochastic Oscillator | 45.05 | 57.79 |
Natural Gas Services Group Inc provides natural gas compression equipment and services to the energy industry. The company manufactures, fabricates, rents, sells, and maintains natural gas compressors and flare systems for oil and natural gas production and plant facilities. Its operating units include Rental, Sales, and Aftermarket services. It operates in one reporting segment. The company generates the majority of its revenue by renting out low- to medium-horsepower compression equipment to natural gas production companies in unconventional oil and gas regions of the United States.
Mobia Medical Inc is a commercial-stage medical device company redefining stroke recovery for survivors living with life-altering motor impairments. The company develops, markets and sells devices for the treatment of medical conditions. Its flagship device is the Vivistim Paired Vagus Nerve Stimulation system, which is used to support motor function rehabilitation in patients with chronic ischemic stroke. The company generates all of its revenue from the sale of the Vivistim System to customers, mainly primary and comprehensive stroke centers, in the United States.